Mesirow Financial Investment Management, Inc. Icad Inc Transaction History

Mesirow Financial Investment Management, Inc.

$4.94 Billion
Q3 2024

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 02, 2022	SELL	$3.92 - $7.48 $84,334 - $160,924	-21,514 Closed	0 $0
Q4 2021 Jan 14, 2022	SELL	$6.7 - $11.38 $76,266 - $129,538	-11,383 Reduced 34.6%	21,514 $155,000
Q3 2021 Oct 20, 2021	SELL	$10.11 - $17.56 $10,625 - $18,455	-1,051 Reduced 3.1%	32,897 $354,000
Q2 2021 Jul 23, 2021	BUY	$14.9 - $20.82 $1,713 - $2,394	115 Added 0.34%	33,948 $588,000
Q1 2021 Apr 14, 2021	SELL	$12.57 - $21.22 $14,417 - $24,339	-1,147 Reduced 3.28%	33,833 $718,000
Q4 2020 Jan 14, 2021	BUY	$8.73 - $14.56 $16,665 - $27,795	1,909 Added 5.77%	34,980 $0
Q3 2020 Oct 13, 2020	BUY	$8.56 - $11.6 $283,087 - $383,623	33,071 New	33,071 $291,000

Others Institutions Holding ICAD

# of Institutions

Shares Held

5.45M

Call Options Held

3.6K

Put Options Held

14.6K

View Full List

About ICAD INC

Ticker ICAD
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 25,333,900
Market Cap $42.6M
Description
iCAD, Inc. provides image analysis, workflow solutions, and radiation therapy for the treatment of cancer in the United States. It operates through two segments, Cancer Detection and Cancer Therapy. The company offers PowerLook platform, which hosts the AI algorithm solutions and manages the communications between imaging acquisition systems, an...

More about ICAD

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Mesirow Financial Investment Management, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Mesirow Financial Investment Management, Inc. with notifications on news.

Account